17 June 2020
Geneva – Celebrating ten years of operations, the Medicines Patent Pool (MPP) launched its newly-revamped website today. Since its establishment in 2010 by Unitaid, the organization has been making medicines affordable and accessible for those in need.
The revamped website is easier to navigate, comes with a fresh look and offers new interactive features such as maps that let you follow country-wise progress from patent status to products supplied, all in one place. The new website also showcases MPP’s achievements – from the 12 billion doses supplied across 131 countries around the world to the partnerships fostered along the way – with originators, generic manufacturers, governments, civil society, patient groups, medical experts, international organizations and funders.
As before, the website is also a gateway to vital resources – from MPP’s medicines and patents database MedsPaL to latest updates on how MPP is contributing to the fight against COVID-19.
Explore all this and more at https://medicinespatentpool.org/
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.